טוען...
Patient’s experience with subcutaneous and oral methotrexate for the treatment of rheumatoid arthritis
BACKGROUND: Despite the prominent position of methotrexate (MTX) in Rheumatoid Arthiris (RA) therapeutics, its real-world effectiveness may be influenced by a relative lack of tolerability or other side effects that physicians may not be aware of but that are bothersome to patients. The aim of this...
שמור ב:
| הוצא לאור ב: | BMC Musculoskelet Disord |
|---|---|
| Main Authors: | , , , , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
BioMed Central
2016
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5037591/ https://ncbi.nlm.nih.gov/pubmed/27669978 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12891-016-1254-x |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|